Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
1.100
+0.050 (4.76%)
At close: Dec 20, 2024, 4:00 PM
1.110
+0.010 (0.91%)
After-hours: Dec 20, 2024, 5:11 PM EST
Century Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 94 | 199 | 303 | 867 | - | - |
Market Cap Growth | 21.19% | -34.34% | -65.09% | - | - | - |
Enterprise Value | -50 | 77 | -6 | 597 | - | - |
Last Close Price | 1.10 | 3.32 | 5.13 | 15.86 | - | - |
PS Ratio | 29.63 | 88.88 | 58.19 | - | - | - |
PB Ratio | 0.48 | 1.08 | 1.00 | 2.19 | - | - |
P/TBV Ratio | 0.92 | 1.08 | 1.00 | 2.19 | - | - |
P/OCF Ratio | - | - | 21.53 | - | - | - |
EV/Sales Ratio | 1.80 | 34.33 | - | - | - | - |
Debt / Equity Ratio | 0.28 | 0.26 | 0.16 | 0.06 | 0.29 | - |
Asset Turnover | 0.01 | 0.01 | 0.01 | - | - | - |
Quick Ratio | 10.06 | 9.80 | 10.61 | 14.25 | 6.33 | 27.28 |
Current Ratio | 10.39 | 9.92 | 10.72 | 14.57 | 6.51 | 28.10 |
Return on Equity (ROE) | -62.61% | -56.07% | -37.46% | -40.81% | -66.45% | - |
Return on Assets (ROA) | -20.90% | -18.47% | -16.75% | -21.80% | -31.10% | - |
Return on Capital (ROIC) | -31.78% | -26.74% | -20.01% | -22.97% | -33.63% | - |
Earnings Yield | -138.87% | -68.80% | -43.28% | -11.06% | - | - |
FCF Yield | -120.94% | -51.39% | -5.47% | -15.46% | - | - |
Buyback Yield / Dilution | -22.76% | -2.70% | -78.30% | -332.95% | -10.43% | - |
Total Shareholder Return | -22.76% | -2.70% | -78.30% | -332.95% | -10.43% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.